Skip to content
10-Q

Quarterly Report

AEOLUS PHARMACEUTICALS, INC.

0001654954-17-001178

← back to feed
Filed
Feb 17, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Feb 17, 2017 152.09M sh
Shares Diluted Q1 2017 · Dec 31, 2016 152.09K sh
Shares Diluted Q1 2017 · Dec 31, 2015 139.44K sh
Operating Cash Flow Q1 2017 · Dec 31, 2016 −$1.26M
Operating Cash Flow Q1 2017 · Dec 31, 2015 −$820K
Cash And Equivalents Q1 2017 · Dec 31, 2016 $1.9M
Cash And Equivalents Q1 2017 · Sep 30, 2016 $3.16M
Cash And Equivalents Q1 2017 · Dec 31, 2015 $5.44M
Cash And Equivalents Q1 2017 · Sep 30, 2015 $94K
Stockholders Equity Q1 2017 · Dec 31, 2016 $2.14M
Stockholders Equity Q1 2017 · Sep 30, 2016 $3.2M
Current Liabilities Q1 2017 · Dec 31, 2016 $514K
Current Liabilities Q1 2017 · Sep 30, 2016 $972K
Total Liabilities Q1 2017 · Dec 31, 2016 $514K
Total Liabilities Q1 2017 · Sep 30, 2016 $972K
Current Assets Q1 2017 · Dec 31, 2016 $2.62M
Current Assets Q1 2017 · Sep 30, 2016 $4.14M
Total Assets Q1 2017 · Dec 31, 2016 $2.65M
Total Assets Q1 2017 · Sep 30, 2016 $4.17M
Eps Diluted Q1 2017 · Dec 31, 2016 −$0.01
Eps Diluted Q1 2017 · Dec 31, 2015 −$0.01
Eps Basic Q1 2017 · Dec 31, 2016 −$0.01
Eps Basic Q1 2017 · Dec 31, 2015 −$0.01
Sga Expense Q1 2017 · Dec 31, 2016 $681K
Sga Expense Q1 2017 · Dec 31, 2015 $561K
Rd Expense Q1 2017 · Dec 31, 2016 $489K
Rd Expense Q1 2017 · Dec 31, 2015 $492K
Net Income Q1 2017 · Dec 31, 2016 −$1.09M
Net Income Q1 2017 · Dec 31, 2015 −$1.03M
Operating Income Q1 2017 · Dec 31, 2016 −$1.09M
Operating Income Q1 2017 · Dec 31, 2015 −$748K